Prevalence of beryllium sensitization among department of defense conventional munitions workers at low risk for exposure

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 3, 2011, Pages 258-265

  Mikulski, Marek A ^a   Sanderson, Wayne T ^a,b   Leonard, Stephanie A ^a   Lourens, Spencer ^a   Field, R William ^a   Sprince, Nancy L ^a   Fuortes, Laurence J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; BERYLLIUM; COPPER;

ADULT; AGED; ARTICLE; BERYLLIOSIS; BERYLLIUM SENSITIZATION; CHEMOSENSITIZATION; CIVIL DEFENSE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FIREARM; HUMAN; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MUNITION WORKER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PREVALENCE; SCREENING; TOOL USE; WORKER;

EID: 79953059550     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31820a408a     Document Type: Article

References (56)

1. Kreiss K, Newman LS, Mroz MM, Campbell PA. Screening blood test iden-tifies subclinical beryllium disease. J Occup Med. 1989;31:603-608. (Pubitemid 19179743)
2. Kreiss K, Mroz MM, Zhen B, Martyny JW, Newman LS. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis. 1993;148:985-991. (Pubitemid 23301218)
3. Stange AW, Furman FJ, Hilmas DE. Rocky flats beryllium health surveillance. Environ Health Perspect. 1996;104:981-986. (Pubitemid 26402341)
4. Stange AW, Hilmas DE, Furman FJ, Gatliffe TR. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility. Appl Occup Environ Hyg. 2001;16:405-417. (Pubitemid 32182987)
5. Frome EL, Newman LS, Cragle DL, Colyer SP, Wambach PF. Identifica-tion of an abnormal beryllium lymphocyte proliferation test. Toxicology. 2003;183:39-56. (Pubitemid 36005388)
6. Sackett HM, Maier LA, Silveira LJ, et al. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med. 2004;46:953-961. (Pubitemid 39237556)
7. Welch L, Ringen K, Bingham E, et al. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites. Am JInd Med. 2004;46:207-218. (Pubitemid 39180816)
8. Arjomandi M, Seward J, Gotway M, et al. Low prevalence of chronic beryl-lium disease among workers at a nuclear weapons research and development facility. J Occup Environ Med. 2010;52:647-652.
9. Stonehouse JA, Zenczak S. Properties, production, processes and application. In: Rossman MD, Preuss OP, Powers MB, eds. Beryllium: Biomedical and Environmental Aspects. Baltimore, MD: Williams andWilkins; 1991:27-55.
10. Henneberger PK, Goe SK, Miller WE, Doney B, Groce DW. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J Occup Environ Hyg. 2004;1: 648-659. (Pubitemid 39387567)
11. Taiwo, OA, Slade MD, Cantley LF, et al. Beryllium sensitization in aluminum smelterworkers. J Occup Environ Med. 2008;50:157-162.
12. Taiwo OA, Slade MD, Cantley LF, Kirsche JC, Wesdock JC, Cullen MR. Prevalence of beryllium sensitization among aluminum smelter workers. Occup Med. 2010;60:569-571.
13. Rosenman K, Hertzberg V, Rice C, et al. Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect. 2005;113:1366-1372. (Pubitemid 41511994)
14. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker ofberyllium disease. Science. 1993;262:242-244. (Pubitemid 23344468)
15. Maier LA. Genetic and exposure risks for chronic beryllium disease. Clin Chest Med. 2002;23:827-839. (Pubitemid 36090314)
16. Kreiss K, Wasserman S, Mroz MM, Newman LS. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med. 1993;35:267-274. (Pubitemid 23084157)
17. Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna B. Risks ofberyllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med. 1997;54:605-612. (Pubitemid 27374989)
18. McCawley MA, Kent MS, Berakis MT. Ultrafine beryllium number concen-tration as a possible metric for chronic beryllium disease risk. Appl Occup Environ Hyg. 2001:165:631-8. (Pubitemid 32428745)
19. Newman LS, Mroz M, Maier LA, Daniloff EM, Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium ma-chining plant. J Occup Environ Med. 2001;43:231-237. (Pubitemid 32238502)
20. Stefaniak AB, Hoover MD, Dickerson RM, et al. Surface area ofrespirable beryllium metal, oxide, and copper alloy aerosols and implications for as-sessment of exposure risk of chronic beryllium disease. AIHA J. 2003;64: 297-305. (Pubitemid 36994497)
21. Stefaniak AB, Hoover MD, Day GA, et al. Characterizationofphysicochem- ical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. J Environ Monit. 2004;6:523-532. (Pubitemid 38869579)
22. Schuler CR, Kent MS, Deubner DC, et al. Process-related risk ofberyllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med. 2005;47:195-205. (Pubitemid 40326251)
23. Kreiss K, Day GA, Schuler CR. Beryllium: a modern industrial hazard. Annu Rev Public Health. 2007;28:259-277. (Pubitemid 46833343)
24. Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study ofdisease risk. Am JRespir Crit Care Med. 2005;171:54-60. (Pubitemid 40051695)
25. Cummings KJ, Deubner DC, Day GA, et al. Enhanced preventive program at a beryllium oxide ceramics facility reduces beryllium sensitisation among newworkers. Occup Environ Med. 2007;64:134-140.
26. Madl AK, Unice K, Brown JL, Kolanz ME, Kent MS. Exposure-response anal-ysis for beryllium sensitization and chronic beryllium disease among workers in aberylliummetalmachining plant. J Occup Environ Hyg. 2007;4:448-466.
27. Kalra R, Singh SP, Savage SM, Finch GL, Sopori ML. Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther. 2000;293:166-171. (Pubitemid 30180936)
28. Kalra R, Singh SP, Kracko D, Matta SG, Sharp BM, Sopori ML. Chronic self-administration ofnicotine in rats impairs T cell responsiveness. J Pharmacol Exp Ther. 2002;302:935-939. (Pubitemid 34920213)
29. Deodhar SD, Barna B, Van Ordstrand HS. A study of the immunologic aspects ofchronicberylliosis. Chest. 1973;63:309-313.
30. Rom WN, Lockey JE, Bang KM, Dewitt C, Johns RE. Reversible beryl-lium sensitization in a prospective study ofberyllium workers. Arch Environ Health. 1983;38:302-307. (Pubitemid 14250051)
31. Mikulski M, Leonard S, Sanderson W, Hartley PG, Sprince NL, Fuortes LJ. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the cold war era [published online ahead ofprint October 28, 2010]. Am J Ind Med. doi: 10.1002/ajim.20913.
32. Sanderson WT, Petersen MR, Ward EM. Estimating historical exposures ofworkers in a beryllium manufacturing plant. Am J Ind Med. 2001;39: 145-157. (Pubitemid 32147532)
33. Sanderson WT, Leonard S, Ott D, Fuortes L, Field W. Beryllium surface levels in a military ammunition plant. J Occup Environ Hyg. 2008;5:475-481. (Pubitemid 351892466)
34. Frome EL, Smith MH, Littlefield LG, Neubert RL, Colyer SP. Statistical methods for the blood beryllium lymphocyte proliferationtest. Environ Health Perspect. 1996;104:957-968 (Pubitemid 26402338)
35. US Department of Energy. DOE-SPEC-1142-2001. Beryllium Lymphocyte Proliferation Testing (BeLPT). Washington, DC: US Department of Energy; 2001.
36. Middleton DC, Fink J, Kowalski PJ, Lewin MD, Sinks T. Optimizing BeLPT criteria for beryllium sensitization. Am J Ind Med. 2006;51:166-172.
37. Middleton DC, Kowalski PJ. Advances in identifying beryllium sensitization and disease. Int J Environ Re Public Health. 2010;7:115-124.
38. Miller MR, Hankinson J, Pellegrino R, et al. Standardisation ofspirometry. Eur Respir J. 2005;26:319-338.
39. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-187. (Pubitemid 29036522)
40. Miller A, Thornton J, Warshaw R, Anderson H, Teirstein A, Selikoff I. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Am Rev Respir Dis. 1983;127:270-277.
41. Hansell DM, Kerr IH. The Role ofhigh resolution computed tomography in the diagnosis of interstitial lung disease. Thorax. 1991;46:77-84.
42. American Thoracic Society European Respiratory Society American Thoracic Society/European Respiratory Society international multidisci-plinary consensus classification ofthe idiopathic interstitial pneumonias. Am JRespir Crit Care Med. 2002;165:277-304.
43. Gotway MB, Reddy GP, Webb WR, Elicker BM, Leung JW. High resolution CT of the lung: patterns of disease and differential diagnoses. Radiol Clin North Am. 2005;43:513-42. (Pubitemid 40545049)
44. SAS. Version 9.2. Cary, NC: SAS Institute Inc; 2002-2008.
45. Agresti A. Categorical Data Analysis. 2nd ed. Hoboken, NJ: Wiley. 2002.
46. Pauwels R, Buist S, Calverley P, Jenkins C, Hurd S. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung dis-ease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary Am JRespir Crit Care Med. 2001;163:1256-1276. (Pubitemid 32378468)
47. Rodrigues EG, McClean MD, Weinberg J, Pepper LD. Beryllium sensitization and lung function among former workers at the Nevada test site. Am J Ind Med. 2008;51:512-523. (Pubitemid 351842315)
48. Silveira L, Bausch M, Mroz M, Maier L, Newman L. Beryllium sensitization inthe "generalpopulation."Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:157.
49. Duggal M, Deubner DC, Curtis AM, Cullen MR. Long-term follow-up of beryllium sensitized workers from a single employer. BMCPublic Health. 2010;10:5
50. Deubner DC, Goodman M, Iannuzzi J. Variability predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey. App Occup Environ Hyg. 2001;16:521-526. (Pubitemid 32428736)
51. Stange AW, Furman FJ, Hilmas DE. The beryllium lymphocyte prolifera-tion test: relevant issues in beryllium health surveillance. Am J Ind Med. 2004;66:453-462. (Pubitemid 39507658)
52. Landis JR, Koch GG. The measurement ofobserver agreement for categorical data.Biometrics. 1977;33:159-174 (Pubitemid 8054849)
53. McAtee BL, Donovan EP, Gaffney SH, Frede W, Knutsen JS, Paustenbach DJ. Historical analysis ofairborne beryllium concentrations at a copper beryllium machining facility(1964-2000). Ann Occup Hyg. 2009;53:373-382.
54. Newman LS, Buschman DL, Newell JD, Lynch DA. Beryllium disease: assessment withCT Radiology. 1994;190: 835-840.
55. Hoover MD, Finch GL, Mewhinney JA, Edison AF. Release of aerosols during sawing and milling of beryllium metal and beryllium alloys. Appl Occup Environ Hyg. 1990;5:787-791. (Pubitemid 20358945)
56. Tinkle SS, Antonini JM, Rich BA, et al. Skin as a route of exposure and sensitization in chronic beryllium exposure. Environ Health Perspect. 2003;111:1202-1208. (Pubitemid 36939402)